Jane Street’s Centessa Pharmaceuticals CNTA Stock Holding History

Jane Street’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.63M	Sell	40,968 -439,236	-91%	-$11.2M	﹤0.01%	5476
2025 Q4	$12M	Buy	480,204 +456,113	+1,893%	+$11.6M	﹤0.01%	2104
2025 Q3	$584K	Sell	24,091 -70,274	-74%	-$1.25M	﹤0.01%	7517
2025 Q2	$1.24M	Sell	94,365 -56,931	-38%	-$721K	﹤0.01%	5218
2025 Q1	$2.18M	Buy	+151,296	New	+$2.48M	﹤0.01%	4220
2024 Q4	–	Sell	-177,260	Closed	-$2.83M	–	9524
2024 Q3	$2.83M	Buy	+177,260	New	+$2.17M	﹤0.01%	3832
2023 Q2	–	Sell	-40,238	Closed	-$155K	–	8767
2023 Q1	$155K	Buy	40,238 +14,253	+55%	+$52.1K	﹤0.01%	7997
2022 Q4	$80.6K	Sell	25,985 -3,926	-13%	-$14.6K	﹤0.01%	8208
2022 Q3	$120K	Sell	29,911 -9,424	-24%	-$43.1K	﹤0.01%	8548
2022 Q2	$192K	Buy	+39,335	New	+$252K	﹤0.01%	8230

Other funds holding CNTA

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

IVLAV

Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Jane Street's CNTA Position: Q1 2026 in Review

Jane Street reduced its Centessa Pharmaceuticals (CNTA) stake by 91% in Q1 2026, selling an estimated $11.2M and leaving 40,968 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #5476.

Jane Street first reported a position in CNTA in Q2 2022 and has held it in 10 quarters since. The position peaked at $12M in Q4 2025. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

Jane Street held 40,968 shares of Centessa Pharmaceuticals worth $1.63M as of Q1 2026.
Jane Street sold 439,236 Centessa Pharmaceuticals shares in Q1 2026, an estimated $11.2M.
Centessa Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5476 holding.
Jane Street first reported a position in Centessa Pharmaceuticals in Q2 2022 and has held it in 10 quarters since.
Jane Street's Centessa Pharmaceuticals position peaked at $12M in Q4 2025.
161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.